Public Act 103-0543
HB3710 EnrolledLRB103 27320 CPF 53691 b HB3710 Enrolled LRB103 27320 CPF 53691 b
HB3710 Enrolled LRB103 27320 CPF 53691 b
AN ACT concerning health.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 1. Short title. This Act may be cited as the
Alternative Protein Innovation Task Force Act.
Section 5. Definitions. As used in this Act:
"Alternative proteins" means proteins created from
plant-based, fermented, cell-cultured inputs and processes to
create foods that share sensory characteristics with
conventional meat and dairy.
"Cultivated meat" means meat that is produced in a
bioreactor from animal cells using a cell cultivation process.
"Fermented protein" means a protein that is made from
traditional fermentation, biomass fermentation, or precision
fermentation.
"Plant-based protein" means a protein that is produced
directly from a plant.
Section 10. Alternative Protein Innovation Task Force. The
Alternative Protein Innovation Task Force is established for
the purposes of investigating and studying alternative
proteins to identify and evaluate possible opportunities that
the protein innovation and the alternative protein industry
HB3710 Enrolled LRB103 27320 CPF 53691 b
offer in the State. The Task Force shall study and draft a
report on how the State may best support the growing
alternative protein industry in the State. The Task Force
shall: (i) examine the potential economic development benefits
and job creation potential of the plant-based protein,
cultivated meat, and fermented protein industries in the
State; (ii) identify the environmental impacts of alternative
proteins and their supply chains; (iii) examine if alternative
proteins can strengthen the State's food resilience; (iv)
assess how alternative proteins may affect individual health,
public health, and food security in the State; and (v)
identify ways the State may foster the growth of the emerging
alternative protein industry, including by reviewing past and
present efforts made to support the broader biotech and life
science industries.
Section 15. Membership; appointments; meeting.
(a) The Alternative Protein Innovation Task Force shall
consist of the following members:
(1) one member of the Senate, who shall be appointed
by the President of the Senate and shall serve as co-chair
of the Task Force;
(2) one member of the Senate, who shall be appointed
by the Minority Leader of the Senate;
(3) one member of the House of Representatives, who
shall be appointed by the Speaker of the House of
Representatives and shall serve as co-chair of the Task
Force;
(4) one member of the House of Representatives, who
shall be appointed by the Minority Leader of the House of
Representatives;
(5) the Secretary of Commerce and Economic Opportunity
or the Secretary's designee;
(6) the Director of Agriculture or the Director's
designee;
(7) 5 members who are appointed by the Director of
Agriculture. Of the members appointed by the Director of
Agriculture, 3 members shall be commercial producers of
agricultural commodities, of which one member shall be
from the largest statewide agricultural association; and 2
members shall be representatives from the University of
Illinois College of Agricultural, Consumer and
Environmental Sciences engaged in nutritional research;
and
(8) 6 members who are appointed by the Governor. Of
the members appointed by the Governor, 2 members shall be
engaged in academic or scientific research on alternative
protein development at a State college or university; one
member shall be a representative of a nonprofit
organization dedicated to the development and
accessibility of alternative proteins; one member shall be
a representative of the State's agricultural biotechnology
industry; one member shall be the president of the
Illinois Biotechnology Industry Organization or the
organization's designee; and one member shall be a
representative from a multinational food processing and
manufacturing corporation headquartered in this State.
(b) Members of the Task Force shall not receive
compensation for their services to the Task Force.
(c) All appointments shall be made not later than 30 days
after the effective date of this Act.
(d) The co-chairs of the Task Force shall schedule no
fewer than 4 meetings of the Task Force, including not less
than one public hearing. The co-chairs shall convene the first
meeting of the Task Force within 60 days after the effective
date of this Act.
Section 20. Report. The Task Force shall submit a report
of its findings and recommendations to the General Assembly no
later than December 31, 2023.